Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Knowing when long term capital gains apply is vital for optimizing your investment outcomes. Understand your tax benefits to enhance your strategy.
27,839 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A SpaceX IPO could shake up both traditional markets and crypto. This guide explains what spacex coming soon. what me...
A big stake in Sotera Health has caught the market's eye as shares slide. This article breaks down what a $175 millio...
Dogecoin pulled back after a brisk rally, erasing part of yesterday's gains. This guide explains what caused the drop...
SkyX’s Q1 2026 results hint at a company in transition: solid top-line momentum paired with ongoing investments. This...
Micron stock losing ground sparks questions about memory cycles, AI-driven demand, and macro risks. This article brea...
As July 22 approaches, investors wonder if AMD stock could spark a move. This guide breaks down catalysts, risks, and...
Buffett built Berkshire Hathaway on a simple idea: invest in durable businesses and hold them. Here are three of his ...
A solid one-day move in Venture Global stock rose today as analysts lifted price targets and LNG demand expectations ...
Oracle stock down 60% from its peak doesn’t tell the whole story. This article digs into the AI cloud momentum fuelin...
The market mood says AI spending is peaking. But one company’s long-term orders hint at a different story. This guide...
Sea Limited entertained investors with strong earnings yet faced a dramatic intraday drop driven by rising fintech co...